Exosome Diagnostics
Johan Skog has a strong background in the scientific field, specializing in neurology and medical research. Johan started their career as a Post-doc at Umea University from November 2005 to December 2006. Following this, they joined Massachusetts General Hospital/Harvard Medical School as an Assistant in Neurology and continued as a Post-doc from January 2007 to January 2008.
In 2008, Skog became an Instructor at Harvard Medical School, where they worked until July 2010. During this time, they also took on the role of Director of Research at Exosome Diagnostics from May 2008 to February 2013. Johan then assumed the position of Chief Scientific Officer at Exosome Diagnostics from February 2013 to August 2018, before being promoted to the role of Chief Scientific Officer and Vice President from August 2018 onwards.
Overall, Johan Skog has gained extensive experience in scientific research and leadership roles throughout their career, contributing to the field of neurology and medical advancements.
Johan Skog's education history begins in 1996 when they enrolled at Umeå University for their MSc in Biomedicine. Johan successfully completed this program in 2001. In 1999, Johan Skog briefly studied at Griffith University, focusing on Biomedicine. Following this, they returned to Umeå University and pursued a Ph.D. in Medicine, which they completed in 2005.
This person is not in any teams
This person is not in any offices
Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.